At the same time, Dr. Ayaka Nishikawa, General Supervisor of the Dermatology Division, was selected as a Key Opinion Leader (KOL).
SBC Medical Group Holdings (Headquarters: California, USA; CEO: Yoshiyuki Aikawa) announced that Shonan Beauty Clinic, operated with its management support, has been officially certified as a “REJURAN Official Certified Clinic” by PharmaResearch (Headquarters: Gangwon-do, Korea; CEO: Jihoon Sohn), the medical manufacturer behind the Korea-origin aesthetic brand REJURAN. In addition, Dr. Ayaka Nishikawa, who serves as General Supervisor of the Dermatology Division, has been selected as a Key Opinion Leader (KOL), receiving comprehensive recognition from the brand.
The REJURAN brand, provided by PharmaResearch, is a Korea-origin regenerative medicine–based treatment designed to enhance the body’s natural healing power, offering a natural rejuvenation effect. Widely recognized as a leading aesthetic brand, it has been introduced globally—particularly across Asia—earning high acclaim and recognition. Shonan Beauty Clinic was an early adopter of REJURAN, providing this skin-regenerative treatment to a broad range of patients. Its extensive clinical achievements and expertise have now been recognized through its certification as an “Official Certified Clinic.”
In addition, Dr. Ayaka Nishikawa, General Supervisor of the Dermatology Division, has been appointed as a Key Opinion Leader (KOL) in recognition of her longstanding accomplishments and expertise in the field of aesthetic dermatology. These recognitions underscore Shonan Beauty Clinic’s leadership in the regenerative medicine field both in Japan and internationally, and represent an important step toward delivering safe, effective, and trusted treatments to an even greater number of patients.
Looking ahead, SBC Medical Group will continue to strengthen partnerships with advanced medical manufacturers such as PharmaResearch, contributing to the sound development of the aesthetic medicine industry while striving to provide optimal, patient-centered medical care.
Details of the Rejuran treatment provided by Shonan Beauty Clinic can be found here.
About PharmaResearch
Headquartered in Gangwon-do, South Korea, PharmaResearch is a leading company in the field of regenerative medicine. The company develops and provides regenerative medical solutions, including polynucleotide (PN) products utilizing patented technology, and distributes a variety of products in the fields of aesthetic healthcare, plastic surgery, and dermatology worldwide. Its flagship brand, "REJURAN," has garnered high acclaim globally, especially in Asia, for its skin repair and regeneration treatments.
Official Website: https://pharmaresearch.com
Comment from Dr. Ayaka Nishikawa
"I am truly honored to have received certification as a “REJURAN Official Certified Clinic” as well as the appointment as a Key Opinion Leader (KOL) by PharmaResearch. At Shonan Beauty Clinic, we have long recognized the potential of regenerative medicine to enhance the skin’s natural power, and we have been committed to providing safe, reliable, and effective treatments to our patients. Moving forward, I intend to continue leveraging the knowledge gained from clinical practice to further advance evidence-based aesthetic medicine, while striving to deliver trusted care to patients around the world."
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
Contacts
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations
E-mail: ir@sbc-holdings.com